EASL-EASD-EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease

Diabetologia. 2016 Jun;59(6):1121-40. doi: 10.1007/s00125-016-3902-y.

Authors

European Association for the Study of the Liver (EASL); European Association for the Study of Diabetes (EASD); European Association for the Study of Obesity (EASO)

PMID: 27053230
DOI: 10.1007/s00125-016-3902-y

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Humans
Liraglutide / therapeutic use
Liver / drug effects
Liver / metabolism
Liver / pathology
Non-alcoholic Fatty Liver Disease / drug therapy*
Non-alcoholic Fatty Liver Disease / metabolism
Pioglitazone
Risk Factors
Thiazolidinediones / therapeutic use

Substances

Thiazolidinediones
Liraglutide
Pioglitazone